CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...

CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in ...

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...